Could a single pill cure scabies? new study tests three doses

NCT ID NCT05875441

Completed Disease control Sponsor: Medicines Development for Global Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a single dose of an oral drug called moxidectin can cure scabies, a skin condition caused by tiny mites. 200 adults with confirmed scabies received either 8 mg, 16 mg, or 32 mg of moxidectin or a placebo. The main goal was to see if the drug could completely clear the infection by day 28, and to check for side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCABIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

scabies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SCABIES

Contacts and locations

Locations

Advanced Care and Clinical Trials, LLC

Miami, Florida, 33155, United States
Affinity Clinical Research LLC

Tampa, Florida, 33612, United States
Derclinic

San Pedro Sula, Cortez, 21104, Honduras
Evolution Clinical Trials

Miami, Florida, 33016, United States
Hospital y Clinica Bendana

San Pedro Sula, Cortés Department, 21104, Honduras
Instituto Dermatologico Dominicano y Cirugia de Piel

Santo Domingo Oeste, Santo Domingo Province, Dominican Republic
LA Universal Research Center, Inc

Los Angeles, California, 90057, United States
Medical Research of Westchester, Inc

Miami, Florida, 33165, United States
Vargas Clinic

San Salvador, San Salvador Department, 01101, El Salvador

More trials for these conditions

Other studies related to the condition(s) this trial covers.